Cabot (CBT)
(Delayed Data from NYSE)
$110.86 USD
-0.91 (-0.81%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $110.92 +0.06 (0.05%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$110.86 USD
-0.91 (-0.81%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $110.92 +0.06 (0.05%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Zacks News
Cabot (CBT) Earnings Surpass Estimates in Q2, Sales Miss
by Zacks Equity Research
Cabot (CBT) expects demand to be low in the fiscal third quarter due to the impacts of the coronavirus pandemic.
Cabot (CBT) Beats Q2 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 8.45% and -8.26%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Cabot (CBT) Completes Acquisition of SUSN for $115 Million
by Zacks Equity Research
The integration of Cabot's (CBT) portfolio of energy materials and SUSN is expected to create a business that generates sales of around $50 million.
Cabot (CBT) Withdraws FY20 View Amid Coronavirus Pandemic
by Zacks Equity Research
Cabot (CBT) expects financial results to be solid for the fiscal second quarter. However, it is withdrawing the previous financial guidance for fiscal 2020.
Why Is Cabot (CBT) Down 10.9% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Moving Average Crossover Alert: Cabot
by Zacks Equity Research
Cabot Corporation (CBT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Cabot Launches Engineered Elastomer Composites Solutions
by Zacks Equity Research
Cabot's (CBT) E2C solutions are geared to raise the bar in tire performance, while offering tire production efficiencies.
Cabot's (CBT) Earnings and Revenues Trail Estimates in Q1
by Zacks Equity Research
Lower volumes hurt Cabot's (CBT) Reinforcement Materials segment in Q1.
Cabot (CBT) Misses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of -9.21% and -8.40%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cabot (CBT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot (CBT) to Purchase Shenzhen Sanshun Nano New Materials
by Zacks Equity Research
Cabot (CBT) expects the acquisition to deliver innovative solutions that facilitate better battery performance at an optimized price-to-performance ratio.
Cabot (CBT) Down 8.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot Inaugurates Carbon Black Expansion Project in Indonesia
by Zacks Equity Research
Cabot's (CBT) capacity expansion project in Indonesia is part of a broader global capacity expansion and debottlenecking project.
Cabot (CBT) Earnings and Sales Fall Short Of Estimates in Q4
by Zacks Equity Research
Cabot (CBT) witnesses weakness in the China business and global automobile production in fourth-quarter fiscal 2019.
Cabot's New TECHBLAK 85 Series to Meet Sustainability Needs
by Zacks Equity Research
Cabot (CBT) unveils new black masterbatch series, designed to minimize industry's carbon footprint and advance circular economy of plastic raw materials.
Cabot (CBT) Boosts Advanced Carbon Portfolio With ATHLOS CNS
by Zacks Equity Research
Cabot's (CBT) latest conductive carbon additive, ATHLOS CNS, aims at facilitating easier processing of high-performance plastic applications.
Cabot (CBT) Opens Fumed Silica Manufacturing Plant in China
by Zacks Equity Research
The new facility enables Cabot (CBT) to maintain its leadership and become the largest provider of fumed silica in the Chinese market.
Why Is Cabot (CBT) Down 0.4% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cabot's (CBT) Q3 Earnings In Line, Revenues Miss Estimates
by Zacks Equity Research
Cabot (CBT) faces challenges from a weak business environment in China and sustained weakness in automotive production in Q3.
Cabot (CBT) Matches Q3 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 0.00% and -2.27%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cabot (CBT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cabot Concludes Divestment of Specialty Fluids Business
by Zacks Equity Research
The deal enables Cabot (CBT) to focus on growth opportunities in core businesses.
Why Is Cabot (CBT) Down 7.6% Since Last Earnings Report?
by Zacks Equity Research
Cabot (CBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for June 5th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.